Coronary artery bypass grafting with cardiopulmonary bypass versus off-pump cardiopulmonary bypass grafting: does eliminating the pump reduce morbidity and cost?

Five-Year Follow-Up of a Randomized Comparison Between Off-Pump and On-Pump Stable Multivessel Coronary Artery Bypass Grafting. The MASS III Trial

“…Indeed, a recently reported study concluded that off-pump is not associated with decreased cost. 24 On the other hand, indirect costs should be considered. In particular, our data showed notable reductions in blood products administered, time to discharge, time in the operating room, time in the ICU, and time to extubation; consequently, their complications and the overall costs of hospitalization might have been reduced.…”

Custos comparativos entre a revascularização miocárdica com e sem circulação extracorpórea

“…Several studies did not use stabilizers in all patients and, in many of them the equipment is re-usable [8][9][10][11][12][13][14][15][16][17][18] . The criteria for these procedures have not been discussed in depth; however, to ensure our patients' safety, especially those in whom the procedure involved the revascularization of latero-posterior wall of the left ventricle, the use of stabilizer was considered mandatory for all the patients in this group.…”

“…The interest for this technique has motivated by several researchers to evaluate the clinical and economic benefits of this type of intervention [8][9][10][11] . In fact, there was a perspective that, with the decrease in the adverse events caused by the MRS with ECC (SECC), the duration of the operating room stay, ICU stay, with shorter orotracheal intubation time 12 and shorter hospital stay duration, the direct and indirect costs would also markedly decrease.…”

A cirurgia de revascularização do miocárdio sem circulação extracorpórea minimiza o sangramento pós-operatório e a necessidade transfusional

“…Recently, due to the suggestion that myocardial revascularization without extracorporeal circulation reduces morbidity in the surgical treatment of coronary artery disease, its indications expanded to the following patients: those with multivessel disease 22 , high-risk patients 23 , patients with chronic renal diseases 24 , the elderly 25 , and those with ventricular dysfunction 26 . Although most authors support the hypothesis that myocardial revascularization without extracorporeal circulation is associated with lower morbidity, this is still controversial 27,28 . The impact in regard to hospital costs is evident, stimulating even more the comparative studies between the techniques.…”